AI CREATING Psychedelics : Is this the FUTURE of the Psychedelic Industry? (+ MDMA Study Results) Today, we’ll be sharing some GAME changing news for the entire psychedelic-medicines industry!
First, we’ll start with some inspiring results from a few MDMA studies and their implications for companies such as Numinus (NUMI), MindMed (MMED / MNMD / MMQ) and Atai Life Sciences. First we’ll cover MAPS’ Phase III MDMA To Treat PTSD Trial Results. Then, we’ll focus on another study’s results, which implies that MDMA could be an effective treatment for alcoholism.
Then, we’ll shift our focus towards an update on Texas, one of the more conservative U.S. states, and its approval of a Psychedelics Research Bill.
Finally, we’ll share some of the oddest and most exciting news from this week: AI might potentially disrupt the psychedelic industry in the next few decades through the creation of psychedelic medicines.
Timestamps:
0:00 - Intro
1:24 - Maps Phase III Trial Testing MDMA to treat PTSD RESULTS & Implications for
Numinus (NUMI), MindMed (MMED / MNMD / MMQ ), Atai, etc.
3:23 - Imperial College of London Study testing MDMA-assisted psychotherapy to treat Alcoholism
7:29 - Texas House Approves a Psychedelic Research Bill
9:34 - Scientists are Using AI to Develop New Psychedelic Drugs
Links to Maps Phase III MDMA trial to treat PTSD : https://www.nytimes.com/2021/05/03/health/mdma-approval.html
https://maps.org/news/media/9122-maps-phase-3-trial-of-mdma-assisted-therapy-for-ptsd-achieves-successful-results-for-patients-with-severe-chronic-ptsd
Links to the Imperial College of London MDMA study to treat alcoholism: https://www.telegraph.co.uk/health-fitness/body/mdma-cured-alcoholism-inside-remarkable-ectsasy-trial-offering/
https://www.telegraph.co.uk/news/2021/02/22/mdma-could-used-treat-alcohol-addiction/
Link to the Texas House Psychedelics Research Bill: https://www.marijuanamoment.net/texas-house-approves-psychedelics-research-bill-as-marijuana-reform-measures-also-advance/
Link to the article “Scientists are Using AI to Develop New Psychedelic Drugs: https://doubleblindmag.com/artificial-intelligence/
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #PsychedelicStocks #MNMD
Psychable Promotes Psychedelic-Assisted Therapy During Trauma Awareness Month
TreatmentDMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture Exchange
BusinessSingapore Begins Administering Ketamine-Type Therapy for Depression
TreatmentPsychedelic Investment Platform Clarify Pharma to Go Public With £10.5 Million Valuation
BusinessMike Tyson Invests In Psychedelic Wellness Company Wesana Health
Business, CultureNew Players, BUY Ratings, Financial Results & MORE ( MINDMED, NUMI, CMPS, MYCO, FTRP, HAVN, DMT)
VideosAI CREATING Psychedelics : Is this the FUTURE of the Psychedelic Industry? (+ MDMA Study Results)
VideosPsychedelics Helped Her Beat Cancer. Now Ashley Lukens Is Paying It Forward.
CultureNew Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says Expert
TreatmentPsychedelic Business News Spotlight: May 7, 2021
Business